| Shen, Jie |
ESPTTN, NCT06423235: Efficacy and Safety of Prunella Oral Liquid in the Treatment of Thyroid Nodules |
|
|
| Not yet recruiting | 4 | 426 | RoW | regular dose of JiRui® Prunella oral liquid, 2x regular dose of JiRui® Prunella oral liquid, regular dose of placebo, 2x regular dose of placebo | Xintian Pharmaceutical | Thyroid Nodule | 07/25 | 07/28 | | |
UplighTED, NCT06307613: A Study of Efgartigimod PH20 SC Given by Prefilled Syringe in Adults with Thyroid Eye Disease |
|
|
| Recruiting | 3 | 108 | Europe, US, RoW | Efgartigimod PH20 SC, Placebo PH20 SC | argenx | Thyroid Eye Disease | 02/26 | 10/27 | | |
ACHIEVE-3, NCT06045221: A Study of Orforglipron (LY3502970) Compared With Semaglutide in Participants With Type 2 Diabetes Inadequately Controlled With Metformin |
|
|
| Active, not recruiting | 3 | 1576 | Japan, US, RoW | Orforglipron, LY3502970, Semaglutide | Eli Lilly and Company | Type 2 Diabetes | 09/25 | 09/25 | | |
NCT04569916: Radiotherapy Combined With Irinotecan and Apatinib Followed by PD-1 Antibody and Apatinib for Advanced Solid Tumors |
|
|
| Not yet recruiting | 2 | 30 | RoW | radiotherapy, irinotecan liposome, apatinib, Apatinib Mesylate Tablets, PD-1 antibody | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | Solid Tumor | 02/23 | 05/23 | | |
TQB2618-AK105-Ib-03, NCT05834543: Clinical Trial to Evaluate the Safety and Effectiveness of TQB2618 Injection Combined Therapy in Patients With Advanced Esophageal Squamous Cell Carcinoma |
|
|
| Recruiting | 1/2 | 75 | RoW | TQB2618 injection, Penpulimab injection, Paclitaxel, Cisplatin, Penpulimab injection, Paclitaxel, Cisplatin, TQB2618 injection, Penpulimab injection, TQB3617capsules | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Advanced Esophageal Squamous Cell Carcinoma | 12/24 | 12/24 | | |
NCT03710915: A Study of HG146 Capsule in Chinese Subjects with Relapsed and Refractory Multiple Myeloma |
|
|
| Terminated | 1 | 3 | RoW | HG146, HG280146, HG0146, HG280146, HG280146-P1 | HitGen Inc. | Multiple Myeloma, Relapsed and Refractory Multiple Myeloma | 09/22 | 06/23 | | |
NCT06193538: The Safety and Effectiveness of NV-A01 in Glioma Patients |
|
|
| Recruiting | 1 | 15 | RoW | Recombinant NV-A01 adenovirus injection | First Affiliated Hospital of Wannan Medical College | Advanced Glioblastoma Patients | 12/24 | 07/25 | | |
NCT04998422: A Study of HG381 Administered to Patients With Advanced Solid Tumors |
|
|
| Recruiting | 1 | 57 | RoW | HG381, HG381 for Injection | HitGen Inc. | Advanced Solid Tumor | 06/24 | 12/24 | | |
NCT05509790: A Study of LY3484356 in Chinese Participants With Advanced Breast Cancer |
|
|
| Active, not recruiting | 1 | 17 | RoW | LY3484356 | Eli Lilly and Company | Breast Neoplasms | 02/24 | 12/25 | | |
BEST-BAO, NCT05631847: Direct Endovascular Treatment Versus Bridging Treatment In Basilar Artery Occlusive Stroke |
|
|
| Recruiting | N/A | 336 | RoW | Endovascular treatment, Intravenous thrombolysis (Alteplase) | Sichuan Academy of Medical Sciences, Sichuan Provincial People's Hospital | Acute Ischemic Stroke, Basilar Artery Occlusion, Thrombosis, Alteplase, Endovascular Treatment | 01/27 | 05/27 | | |
| Jiang, xiao qing |
NCT06193538: The Safety and Effectiveness of NV-A01 in Glioma Patients |
|
|
| Recruiting | 1 | 15 | RoW | Recombinant NV-A01 adenovirus injection | First Affiliated Hospital of Wannan Medical College | Advanced Glioblastoma Patients | 12/24 | 07/25 | | |
PCI CODE, NCT03852082: Predictors and Clinical Outcomes of Patients With Coronary Heart Disease Co-morbid Depression Post Percutaneous Coronary Intervention |
|
|
| Active, not recruiting | N/A | 2600 | RoW | percutaneous coronary intervention | Nanjing First Hospital, Nanjing Medical University | Coronary Heart Disease, Percutaneous Coronary Intervention, Depression | 09/24 | 09/24 | | |
